Recent studies have confirmed that IDH1 mutations can trigger glioma formation in mice when combined with mutations in other key tumor suppressor genes, such as TP53 (Tumor protein p53) and ATRX (alpha-thalassemia mental retardation X-linked) [46]. This evidence concerns the gene TP53 and central nervous system cancer.